Article Details

NextCure and Yale Publish New Immuno-Oncology Target, Siglec-15

Retrieved on: 2019-03-04 22:15:00

Tags for this article:

Click the tags to see associated articles and topics

NextCure and Yale Publish New Immuno-Oncology Target, Siglec-15. View article details on hiswai:

Excerpt

<div>All existing investors participated, including Canaan Partners, Lilly Asia Ventures, OrbiMed Advisors, Pfizer, <b>Sofinnova Ventures</b> and Alexandria ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up